Brain Scientific Stock Analysis
| BRSF Stock | USD 0.0001 0.00 0.00% |
Brain Scientific holds a debt-to-equity ratio of 0.179. Brain Scientific's financial risk is the risk to Brain Scientific stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Brain Scientific's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Brain Scientific's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Brain Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect Brain Scientific's stakeholders.
For many companies, including Brain Scientific, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Brain Scientific, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Brain Scientific's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Brain Scientific's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Brain Scientific is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Brain Scientific to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Brain Scientific is said to be less leveraged. If creditors hold a majority of Brain Scientific's assets, the Company is said to be highly leveraged.
Brain Scientific is overvalued with Real Value of 9.6E-5 and Hype Value of 1.08E-4. The main objective of Brain Scientific pink sheet analysis is to determine its intrinsic value, which is an estimate of what Brain Scientific is worth, separate from its market price. There are two main types of Brain Scientific's stock analysis: fundamental analysis and technical analysis.
The Brain Scientific pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Brain Scientific's ongoing operational relationships across important fundamental and technical indicators.
Brain |
Brain Pink Sheet Analysis Notes
About 24.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.3. Brain Scientific had not issued any dividends in recent years. The entity had 1:85 split on the 3rd of February 2023. Brain Scientific Inc., a medtech company, provides neurology-focused medical devices and electric motors in the United States. Brain Scientific Inc. was founded in 2013 and is headquartered in Sarasota, Florida. Brain Scientific operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 28 people.The quote for Brain Scientific is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Brain Scientific please contact Hassan Kotob at 917-388-1578 or go to https://www.brainscientific.com.Brain Scientific Investment Alerts
| Brain Scientific is way too risky over 90 days horizon | |
| Brain Scientific has some characteristics of a very speculative penny stock | |
| Brain Scientific appears to be risky and price may revert if volatility continues | |
| Brain Scientific currently holds 9.97 M in liabilities with Debt to Equity (D/E) ratio of 0.18, which may suggest the company is not taking enough advantage from borrowing. Brain Scientific has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Brain Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Brain Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Brain Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Brain to invest in growth at high rates of return. When we think about Brain Scientific's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 265.75 K. Net Loss for the year was (9.1 M) with profit before overhead, payroll, taxes, and interest of 83.23 K. | |
| Brain Scientific currently holds about 3.54 M in cash with (5.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 24.0% of Brain Scientific shares are held by company insiders |
Brain Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 316.21 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Brain Scientific's market, we take the total number of its shares issued and multiply it by Brain Scientific's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 6th of February, Brain Scientific shows the mean deviation of 3.01, and Risk Adjusted Performance of 0.0506. Brain Scientific technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Brain Scientific risk adjusted performance, standard deviation, as well as the relationship between the Standard Deviation and maximum drawdown to decide if Brain Scientific is priced correctly, providing market reflects its regular price of 1.0E-4 per share. As Brain Scientific appears to be a penny stock we also recommend to validate its information ratio numbers.Brain Scientific Price Movement Analysis
The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Moving Average is predictive technique used to analyze Brain Scientific price data points by creating a series of averages of different subsets of Brain Scientific entire price series.
Brain Scientific Outstanding Bonds
Brain Scientific issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Brain Scientific uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Brain bonds can be classified according to their maturity, which is the date when Brain Scientific has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Brain Scientific Predictive Daily Indicators
Brain Scientific intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Brain Scientific pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
Brain Scientific Forecast Models
Brain Scientific's time-series forecasting models are one of many Brain Scientific's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Brain Scientific's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Brain Scientific Debt to Cash Allocation
Many companies such as Brain Scientific, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Brain Scientific currently holds 9.97 M in liabilities with Debt to Equity (D/E) ratio of 0.18, which may suggest the company is not taking enough advantage from borrowing. Brain Scientific has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Brain Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Brain Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Brain Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Brain to invest in growth at high rates of return. When we think about Brain Scientific's use of debt, we should always consider it together with cash and equity.Brain Scientific Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Brain Scientific's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Brain Scientific, which in turn will lower the firm's financial flexibility.Brain Scientific Corporate Bonds Issued
Most Brain bonds can be classified according to their maturity, which is the date when Brain Scientific has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
About Brain Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Brain Scientific prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Brain shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Brain Scientific. By using and applying Brain Pink Sheet analysis, traders can create a robust methodology for identifying Brain entry and exit points for their positions.
Brain Scientific Inc., a medtech company, provides neurology-focused medical devices and electric motors in the United States. Brain Scientific Inc. was founded in 2013 and is headquartered in Sarasota, Florida. Brain Scientific operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 28 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Brain Scientific to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
| All Next | Launch Module |
Complementary Tools for Brain Pink Sheet analysis
When running Brain Scientific's price analysis, check to measure Brain Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brain Scientific is operating at the current time. Most of Brain Scientific's value examination focuses on studying past and present price action to predict the probability of Brain Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brain Scientific's price. Additionally, you may evaluate how the addition of Brain Scientific to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |